Lixte Biotechnology Holdings, Inc. Announces the Closing of $1.5 Million Registered Direct Offering
PASADENA, CALIF, July 08, 2025 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) (the “Company”), a clinical stage pharmaceutical...